Human endogenous retroviruses in the aetiology of MS

T Christensen1

  • 1Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Insights

Investigating human endogenous retroviruses (HERVs) in multiple sclerosis (MS) reveals potential links. HERV activation and specific proteins may play a role in MS pathogenesis, suggesting novel therapeutic targets.

Area of Science:

  • Neurology
  • Immunology
  • Virology

Background:

  • Multiple sclerosis (MS) is an immune-mediated neurologic disease with suspected links to human endogenous retroviruses (HERVs).
  • HERVs are retroviral sequences integrated into the human genome, some of which are implicated in disease pathology in other species.
  • Specific HERV families (e.g., HERV-H/F, HERV-W/MSRV) show activation in MS patients' nervous systems and peripheral cells.

Purpose of the Study:

  • To explore the association between HERVs and multiple sclerosis.
  • To investigate the pathogenic potential of HERV-encoded genes and proteins in MS.
  • To highlight the role of regulatory pathways, epigenetics, and restriction factors in HERV activation relevant to MS.

Main Methods:

  • Review of existing research on HERV involvement in neurological diseases.
  • Analysis of documented HERV family activation in the central nervous system and periphery of MS patients.
  • Examination of the potential pathogenic role of HERV envelope proteins (Envs).

Main Results:

  • Strong indications of an association between MS and HERVs, particularly specific families like HERV-H/F and HERV-W/MSRV.
  • HERV-encoded genes and envelope proteins show strong association with MS and possess pathogenic potential.
  • Emerging evidence points to the importance of epigenetic regulation and restriction factors in controlling HERV activation.

Conclusions:

  • HERVs are strongly implicated in multiple sclerosis, with specific HERV elements potentially contributing to disease pathogenesis.
  • Understanding HERV regulation is crucial for elucidating their role in MS.
  • Antiretroviral therapies targeting HERVs represent a promising novel therapeutic strategy for MS, supported by observations in HIV-infected individuals.

Related Concept Videos

Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
15.0K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.5K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.0K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.9K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K